
Cassel Salpeter & Co.’s Q3 healthcare update points to disrupted NIH grant processing, FDA attrition, and tariffs as pressures on drug development and early-stage financing.
The capabilities of
Investments in both equipment and its 47,000-square-foot facility allow for generating a daily test volume of approximately 144,000 tests on 60,000 samples per day. DCR rate of delivery is 99.8 percent.
Each clinical project has a project manager to ensure client-specific requirements are met and communication is maintained. Data systems provide fully compliant order entry and reporting with the ability to use anywhere.
The






